Skip to main content

DANAHER CORP

corporate_fare Company Profile

DANAHER CORP

DHR·NYSE·Industrial Applications And Services·CIK 0000313616

Danaher is a global science and technology innovator focused on improving human health. The company operates through more than 15 operating companies, which hold leadership positions in the biotechnology, life sciences, and diagnostics sectors. These businesses are organized into three segments: Biotechnology, Life Sciences, and Diagnostics. Danaher's businesses typically sell a high level of products and services on a recurring basis, primarily through a direct sales model, to a geographically diverse customer base. The company's research and development, manufacturing, sales, distribution, service, and administrative facilities are located in approximately 50 countries. Danaher aims to create shareholder value by strengthening its competitive advantage through the DANAHER BUSINESS SYSTEM ("DBS") tools and culture, enhancing its portfolio in attractive science and technology markets through strategic capital allocation, and consistently attracting and retaining exceptional talent. The company measures its progress against these priorities over the long-term using financial metrics related to revenue growth, profitability, cash flow, and capital returns, as well as certain non-financial metrics. Danaher acquires businesses and makes investments that either complement its existing portfolio or expand into new attractive markets. It also continually assesses the strategic fit of its existing businesses and may separate or dispose of businesses based on strategic and other considerations.

DANAHER CORP (NYSE:DHR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 31 items for DHR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for DHR spans 8-K, 10-Q, 424B5, FWP.

Recent high-impact activity:

  • Danaher Names Julie Sawyer Montgomery CEO, Lifts 2026 EPS Outlook to $8.57–$8.62
  • Danaher Lifts Full-Year EPS Outlook After Q3 Beat
  • Danaher Posts Q3 Adjusted EPS of $2.11
  • Danaher Beats Q3, Raises Full-Year Adjusted EPS Guidance to $8.57-$8.62
  • Danaher Q3 EPS $1.75; Sales Up 8.5% on Masimo, Adds $1.4B StatLab Deal

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$24.57B
Net Income
$3.61B
Diluted EPS
$5.05
Op. Cash Flow
$6.42B
Free Cash Flow
$5.26B
Gross Profit
$14.52B
Operating Income
$4.69B
Cash & Equivalents
$4.62B
Total Debt
$18.42B
Debt / Equity
0.35×
Net Margin
14.7%
Shares Outstanding
706.9M sh
Source: 10-K · filed 2026-02-24 · accession 0000313616-26-000062

Short Interest & Short Volume

1.76 days to cover

FINRA reported short interest of 8,383,201 shares in DHR as of the October 30, 2026 settlement, a 2.9% increase from the prior period — about 1.8 days to cover at its recent average daily volume. On November 20, 2026, 24.0% of DHR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)8,383,201 shares as of October 30, 2026
Change vs prior period▲ 2.9%
Days to cover1.76 at avg daily volume of 4,754,477
Daily short volume (FINRA facilities)24.0% of 1,401,395 shares on November 20, 2026
5-day average short volume29.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with D →
$221.31 +0.43% today
52-week range · as of 2026-10-20 $160.93 – $242.8
Market cap
$155.03B
Volume
4M (1.0× avg)
3-mo avg 4.1M
Live data · 2026-11-21 07:01 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DHR - Latest Insights

DHR
Nov 02, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $237.50
Real-time Price: $221.31 info
Change: -$16.19 (-7%) info
Market Cap: $155.03B info
DHR
Oct 21, 2026, 11:24 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $230.83
Real-time Price: $221.31 info
Change: -$9.52 (-4%) info
Market Cap: $155.03B info
DHR
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $221.00
Real-time Price: $221.31 info
Change: +$0.310 (+0.14%) info
Market Cap: $155.03B info
DHR
Oct 20, 2026, 5:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $221.20
Real-time Price: $221.31 info
Change: +$0.110 (+0.05%) info
Market Cap: $155.03B info
DHR
Oct 20, 2026, 5:40 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $221.20
Real-time Price: $221.31 info
Change: +$0.110 (+0.05%) info
Market Cap: $155.03B info
DHR
Aug 03, 2026, 4:27 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $203.77
Real-time Price: $221.31 info
Change: +$17.54 (+9%) info
Market Cap: $155.03B info
DHR
Jul 22, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $178.80
Real-time Price: $221.31 info
Change: +$42.51 (+24%) info
Market Cap: $155.03B info
DHR
Jul 21, 2026, 1:23 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $176.50
Real-time Price: $221.31 info
Change: +$44.81 (+25%) info
Market Cap: $155.03B info
DHR
Jul 21, 2026, 9:08 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $171.90
Real-time Price: $221.31 info
Change: +$49.41 (+29%) info
Market Cap: $155.03B info
DHR
Jul 21, 2026, 6:14 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $184.00
Real-time Price: $221.31 info
Change: +$37.31 (+20%) info
Market Cap: $155.03B info
DHR
Jul 21, 2026, 6:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $201.51
Real-time Price: $221.31 info
Change: +$19.80 (+10%) info
Market Cap: $155.03B info
DHR
Jul 20, 2026, 5:55 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $184.65
Real-time Price: $221.31 info
Change: +$36.66 (+20%) info
Market Cap: $155.03B info
DHR
Jul 20, 2026, 5:48 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $184.65
Real-time Price: $221.31 info
Change: +$36.66 (+20%) info
Market Cap: $155.03B info
DHR
Jul 14, 2026, 5:11 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $199.05
Real-time Price: $221.31 info
Change: +$22.26 (+11%) info
Market Cap: $155.03B info
DHR
Jun 10, 2026, 8:56 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $187.50
Real-time Price: $221.31 info
Change: +$33.81 (+18%) info
Market Cap: $155.03B info
DHR
Jun 03, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $178.08
Real-time Price: $221.31 info
Change: +$43.23 (+24%) info
Market Cap: $155.03B info
DHR
Apr 29, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $178.50
Real-time Price: $221.31 info
Change: +$42.81 (+24%) info
Market Cap: $155.03B info
DHR
Apr 23, 2026, 4:15 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $178.55
Real-time Price: $221.31 info
Change: +$42.76 (+24%) info
Market Cap: $155.03B info
DHR
Apr 22, 2026, 6:03 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $183.81
Real-time Price: $221.31 info
Change: +$37.50 (+20%) info
Market Cap: $155.03B info
DHR
Apr 22, 2026, 4:34 PM EDT
Filing Type: FWP
Importance Score:
8
Price at Filing: $184.00
Real-time Price: $221.31 info
Change: +$37.31 (+20%) info
Market Cap: $155.03B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets